ChemMedChem · 2025
Targeting Ubiquitin-Specific Protease 7 with Novel 5-Amino-Pyrazole Inhibitors: Design, Synthesis, and Biological Evaluation.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lusardi Matteo, Morretta Elva, Spallarossa Andrea, Chiara Monti Maria, Rosano Camillo, Iervasi Erika, Ponassi Marco, Mori Matteo, Meneghetti Fiorella, Brullo Chiara
Аннотация
To further extend the structure-activity relationships (SARs) of the previously published ubiquitin-specific protease 7 (USP-7) inhibitor STIRUR-41, a small library of 5-aminopyrazoles 1a-d and 2a-d is designed and synthesized. The chemical identity of the desired structure is confirmed by nuclear magnetic resonance and single crystal X-ray diffraction analyses. All novel derivatives are tested as potential USP-7 inhibitors and compounds 1a-d block enzyme activity in a dose-dependent manner and with lower IC50 values compared to the lead compound STIRUR-41. Notably, 1d, bearing a meta-trifluoromethylphenyl group linked to the carbamate moiety, proved to be the most active candidate. Conversely, compounds belonging to series 2, which possess greater steric hindrance, exhibit no activity. The most effective compounds of series 1 are noncytotoxic across a panel of tumor and normal cell lines at 10 μM concentration. For the most active compound 1d, a parallel artificial membrane permeability assay is also performed, as well as docking and molecular dynamics simulations.
Предметные рубрики MeSH
HumansStructure-Activity RelationshipDrug DesignPyrazolesUbiquitin-Specific Peptidase 7Dose-Response Relationship, DrugMolecular StructureProtease InhibitorsMolecular Docking SimulationMolecular Dynamics SimulationCell Line, TumorUbiquitin ThiolesteraseCrystallography, X-RayEndopeptidasesAntineoplastic Agents